Conferences
PPi provides in-company training on P&R and also speaks at conferences on a broad range of topics relating to healthcare pricing and funding.
We welcome the opportunity to provide tailored training solutions to help companies as well as providing specific guidance on emerging issues. You can see examples of our training and conference programmes in this section. Please contact us to arrange bespoke training programmes for your company.
Pharma Pricing, Reimbursement & Market Access
London, UK - June 10, 2016. Presentation by Frans van Andel on Early Market Access of Health Technologies. Topics covered included importance and mechanisms for early market access, economic evidence, rationale for EAPs, Gain Share model … [Read More...] about Pharma Pricing, Reimbursement & Market Access
World Orphan Drug Conference, USA
Washington DC, USA - 20 April, 2016. Adam Barak presenting at the World Orphan Drugs Conference, Washington Educational Seminar (full day) Challenges and Solutions for Funding Treatment of Rare Diseases: Payers’ Perspectives. PPi’s Adam Barak and … [Read More...] about World Orphan Drug Conference, USA
Orphan Drugs and Rare Diseases
London, UK - 15 March, 2016. Adam Barak presenting at the Orphan Drugs and Rare Disease conference. Conference on considerations for securing early advice in Europe. Providing examples and guidance for companies developing medicines for rare … [Read More...] about Orphan Drugs and Rare Diseases
World Orphan Drug Conference, Europe
Geneva, Switzerland - November 12, 2015. Discussion led by PPi’s Adam Barak on Seeking commercial and development guidance for Orphan Drugs to support Market Access. An assessment of alternative approaches, considerations and examples from 6 … [Read More...] about World Orphan Drug Conference, Europe
Cambridge Rare Disease Network, Inaugural Meeting
Cambridge, UK - September 14, 2015. Presentation by Adam Barak on Engaging with Pharma: Pricing and Reimbursement Perspectives (Rare Diseases). Forum representing interests of patients, governments, manufacturers and academic institutes. Topics … [Read More...] about Cambridge Rare Disease Network, Inaugural Meeting
Pharma Pricing and Market Access, Europe
London, UK - 26 February, 2014. Adam Barak presented on Funding, pricing and patient access approaches for rare disease treatments. Topics covered included challenges for funding rare disease treatments, funding approaches in different countries and … [Read More...] about Pharma Pricing and Market Access, Europe
ISPOR (International Society for Pharmacoeconomics and Outcomes Research) European Congress
Prague, Czech Republic - November 6, 2010. Issues Panel chaired by PPi’s Adam Barak on Greece's national drug budget cut: what will be its impact on Europe? Adam Barak led a discussion including panellists from Greek academic institutions and the … [Read More...] about ISPOR (International Society for Pharmacoeconomics and Outcomes Research) European Congress
Visiongain 9th Annual P&R Conference
London, UK - 28-29 September, 2010. Adam Barak presented on Pricing, Reimbursement and Market Access Strategies for Orphan Medicines. Topics covered included growth of Orphan Drugs, Incentives and European institutional support, pricing approaches … [Read More...] about Visiongain 9th Annual P&R Conference
Generics & patent-Expired Pharmaceutical Market
London, UK - September 16, 2004. IQPC Speaker: Adam Barak, PPi Ltd. Profiting in the Generics & patent-Expired Pharmaceutical Market – Establishing Competitive, Marketing, Regulatory and R&D Strategies and Opportunities Conferences … [Read More...] about Generics & patent-Expired Pharmaceutical Market
An Introduction to the Pharmaceutical Industry Today
London, UK - January 30, 2004. Henry Stewart Conference Studies. Course led by : Adam Barak, PPi Ltd. Course Title: An Introduction to Pharmaceutical Pricing and Reimbursement Conferences … [Read More...] about An Introduction to the Pharmaceutical Industry Today
European Regulatory Affairs, Health Economics & Pricing Symposium
Amman, Jordan - October 14th, 2003. Conference Organiser: Pharmaceutical Training International (PTI) Speaker: Adam Barak, PPi Ltd Introduction to European Pricing & Reimbursement 63 delegates from across Middle East/North Africa including 41 … [Read More...] about European Regulatory Affairs, Health Economics & Pricing Symposium
Defending Value and Maximising Profitability of Innovative Pharmaceuticals over their Entire Life Cycles
London, UK - February, 2003. Henry Stewart Conference Studies. Speaker: Adam Barak, PPi Ltd Handling Patent Loss or Expiry II: Pricing Policy Conferences … [Read More...] about Defending Value and Maximising Profitability of Innovative Pharmaceuticals over their Entire Life Cycles
Conferences
TESTIMONIALS
“With their depth of market access experience across the EU, Adam Barak and his team at PPi Healthcare are well-positioned to provide timely, insightful guidance on pricing and reimbursement. ProMetic’s global strategic launch plans involving ultra-orphan therapies, have been greatly enhanced by our collaboration with PPi.”
Kristine Dorward, Director, Marketing & Business Development, ProMetic Life Sciences Inc.
“I want to let you know that the feedback from my colleagues after your presentation was that they are impressed by the amount of information that you have gathered within the research within such a short period.”
Ramona Schmid, Global Market Access, Pricing and Reimbursement Manager, HRA Pharma
“I have worked with PPi on several projects and I will work with them again. The first project was a European pricing study for an orphan product. Having already completed one study with a competitor, I found the PPi team to be particularly insightful, having taken the time to completely understand this complex project.”
Thomas W. MacAllister JD, PhD, Vice President of R&D and General Counsel, Remedy Pharmaceuticals
“Recently I completed an assessment to inform the collection of pharmacoeconomic data in a clinical study in the US and Europe. The team again were very insightful and we had unexpected value-added when we found a member of the PPi had been involved in the pricing and reimbursement activities relating to one of our comparables. Great team, great results!”
Thomas W. MacAllister JD, PhD, Vice President of R&D and General Counsel, Remedy Pharmaceuticals
